Japan Neurovascular Devices Market Size & Outlook
Japan neurovascular devices market, 2018-2030 (US$M)
Related Markets
Japan neurovascular devices market highlights
- The Japan neurovascular devices market generated a revenue of USD 303.0 million in 2024 and is expected to reach USD 471.0 million by 2030.
- The Japan market is expected to grow at a CAGR of 7.6% from 2025 to 2030.
- In terms of segment, cerebral embolization and aneurysm coiling devices was the largest revenue generating device types in 2024.
- Cerebral Embolization and Aneurysm Coiling Devices is the most lucrative device types segment registering the fastest growth during the forecast period.
Neurovascular devices market data book summary
| Market revenue in 2024 | USD 303.0 million |
| Market revenue in 2030 | USD 471.0 million |
| Growth rate | 7.6% (CAGR from 2025 to 2030) |
| Largest segment | Cerebral embolization and aneurysm coiling devices |
| Fastest growing segment | Cerebral Embolization and Aneurysm Coiling Devices |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices |
| Key market players worldwide | Medtronic PLC, Johnson & Johnson, Penumbra Inc, MicroPort Scientific Corp, Stryker Corp, Terumo Corp, Integra Lifesciences Holdings Corp |
Other key industry trends
- In terms of revenue, Japan accounted for 4.1% of the global neurovascular devices market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan neurovascular devices market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 471.0 million by 2030.
Cerebral embolization and aneurysm coiling devices was the largest segment with a revenue share of 40.53% in 2024. Horizon Databook has segmented the Japan neurovascular devices market based on cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, support devices, trans radial access devices covering the revenue growth of each sub-segment from 2018 to 2030.
Favorable healthcare policies in Japan are among major factors driving neurovascular devices market growth over the forecast period. The Japanese healthcare system ensures that every Japanese citizen is entitled to care throughout the country at all times, even if they are not in their home location.
Furthermore, due to such policies, authorities are upgrading equipment and providing advanced care in every part of the country. Furthermore, the growing geriatric population is one of the major driving factors for market growth in Japan.
According to the Japan Times, in September 2021, 36.17 million people were estimated to be aged 65 years or older. As per WHO, Japan has 23.6% of the population aged 60 years or above and annually, around 20% of older persons suffer from falls, which can lead to mild or severe brain injuries.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neurovascular Devices Market Scope
Neurovascular Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan neurovascular devices market size, by device types, 2018-2030 (US$M)
Japan Neurovascular Devices Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
